Scilex Holding Company (SCLX)
NASDAQ: SCLX · Real-Time Price · USD
18.23
+1.41 (8.38%)
At close: Oct 7, 2025, 4:00 PM EDT
18.23
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:00 PM EDT
Scilex Holding Company Revenue
Scilex Holding Company had revenue of $9.90M in the quarter ending June 30, 2025, a decrease of -39.55%. This brings the company's revenue in the last twelve months to $44.24M, down -12.98% year-over-year. In the year 2024, Scilex Holding Company had annual revenue of $56.59M with 21.07% growth.
Revenue (ttm)
$44.24M
Revenue Growth
-12.98%
P/S Ratio
2.87
Revenue / Employee
$384,661
Employees
115
Market Cap
100.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.59M | 9.85M | 21.07% |
Dec 31, 2023 | 46.74M | 8.71M | 22.90% |
Dec 31, 2022 | 38.03M | 6.72M | 21.45% |
Dec 31, 2021 | 31.32M | 7.76M | 32.92% |
Dec 31, 2020 | 23.56M | 2.53M | 12.01% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SCLX News
- 6 days ago - Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase - GlobeNewsWire
- 11 days ago - Datavault AI Announces Closing of Initial Tranche Investment from Scilex Holding Company - Business Wire
- 11 days ago - Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI - GlobeNewsWire
- 12 days ago - Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI - GlobeNewsWire
- 12 days ago - Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bitcoin - GlobeNewsWire
- 13 days ago - Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management - GlobeNewsWire
- 14 days ago - Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Semnur Common Stock in Exchange for $100 Million in Bitcoin - GlobeNewsWire
- 14 days ago - Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin - GlobeNewsWire